Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
For individuals ready to explore GLP-1 medications and a sustainable approach to weight management, Brello is a trusted telehealth solution that delivers results through convenience, compassion, and clinical expertise
Why Blood Sugar May Not Be Very High In classic DKA: Insulin deficiency severe hyperglycemia In euglycemic DKA: Some insulin is still being administered Blood glucose may appear only mildly elevated But insulin is insufficient to prevent ketogenesis This can delay recognition because: Patients and clinicians may not suspect DKA with glucose under 250 mg/dL Symptoms may initially resemble dehydration or GI illness Additional Contributing Factors GLP-1 use in Type 1 diabetes may also increase DKA risk due to: Vomiting dehydration stress hormones ketone rise Intentional insulin reduction due to fear of hypoglycemia Reduced basal insulin during weight loss Increased glycemic variability from delayed gastric emptying Hypoglycemia and the Insulin Reduction Trap Another issue is the cycle that can develop: Appetite decreases Insulin dose is reduced Hypoglycemia occurs intermittently Insulin is reduced further Ketone production increases Over time, this can push the patient into metabolic instability
Heres a simple guide to follow: Stay Hydrated: Drink plenty of water
Light to moderate activity, even just walking or stretching, can improve both energy and mental well-being
Following specific medication guidelines for reconstitution is vital to ensure efficacy
The FDA expanded Trulicity's usage in November 2022 to include pediatric patients 10 years of age and above, alongside diet and exercise, to improve glycemic control
